Cargando…

Deactivation of ligand-receptor interactions enhancing lymphocyte infiltration drives melanoma resistance to Immune Checkpoint Blockade

Immune checkpoint blockade (ICB) is a promising cancer therapy; however, resistance often develops. To learn more about ICB resistance mechanisms, we developed IRIS (Immunotherapy Resistance cell-cell Interaction Scanner), a machine learning model aimed at identifying candidate ligand-receptor inter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sahni, Sahil, Wang, Binbin, Wu, Di, Dhruba, Saugato Rahman, Nagy, Matthew, Patkar, Sushant, Ferreira, Ingrid, Wang, Kun, Ruppin, Eytan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602042/ https://www.ncbi.nlm.nih.gov/pubmed/37886558 http://dx.doi.org/10.1101/2023.09.20.558683

Ejemplares similares

Functional random forest with applications in dose-response predictions
por: Rahman, Raziur, et al.
Publicado: (2019)

Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
por: Kalaora, Shelly, et al.
Publicado: (2020)

Recursive model for dose-time responses in pharmacological studies
por: Dhruba, Saugato Rahman, et al.
Publicado: (2019)

Application of transfer learning for cancer drug sensitivity prediction
por: Dhruba, Saugato Rahman, et al.
Publicado: (2018)

Decoupling the correlation between cytotoxic and exhausted T lymphocyte transcriptomic signatures enhances melanoma immunotherapy response prediction from tumor expression
por: Wang, Binbin, et al.
Publicado: (2023)

Replenish the source within: Rescuing tumor-infiltrating lymphocytes by double checkpoint blockade
por: Duraiswamy, Jaikumar, et al.
Publicado: (2013)

Immune Checkpoint Blockade to Improve Tumor Infiltrating Lymphocytes for Adoptive Cell Therapy
por: Kodumudi, Krithika N., et al.
Publicado: (2016)

Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs
por: Kundert, Kale, et al.
Publicado: (2019)

Representation of features as images with neighborhood dependencies for compatibility with convolutional neural networks
por: Bazgir, Omid, et al.
Publicado: (2020)

Chromothripsis is correlated with reduced cytotoxic immune infiltration and diminished responsiveness to checkpoint blockade immunotherapy
por: Chu, Han, et al.
Publicado: (2023)

One-carbon unit supplementation fuels tumor-infiltrating T cells and augments checkpoint blockade
por: Xu, Xincheng, et al.
Publicado: (2023)

Tumour mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade
por: Mahmood, Mahnoor, et al.
Publicado: (2023)

The Prognosis and Immune Checkpoint Blockade Efficacy Prediction of Tumor-Infiltrating Immune Cells in Lung Cancer
por: Liu, Xiangzheng, et al.
Publicado: (2021)

Landscape of Infiltrated Immune Cell Characterization in Uveal Melanoma to Improve Immune Checkpoint Blockade Therapy
por: Lv, Xiaohui, et al.
Publicado: (2022)

RNAi-Mediated β-Catenin Inhibition Promotes T Cell Infiltration and Antitumor Activity in Combination with Immune Checkpoint Blockade
por: Ganesh, Shanthi, et al.
Publicado: (2018)

Cancer-Associated Fibroblasts Suppress CD8(+) T-cell Infiltration and Confer Resistance to Immune-Checkpoint Blockade
por: Jenkins, Liam, et al.
Publicado: (2022)

Corticosteroids and immune checkpoint blockade
por: Min, Le, et al.
Publicado: (2015)

Immune checkpoint blockade in HIV
por: Gubser, Celine, et al.
Publicado: (2022)

Epigenetic checkpoint blockade: new booster for immunotherapy
por: Wang, Ziqiao, et al.
Publicado: (2021)

Catalyst deactivation /
Publicado: (1999)

Predictive biomarkers for tumor immune checkpoint blockade
por: Tong, Mengting, et al.
Publicado: (2018)

MCT4 blockade increases the efficacy of immune checkpoint blockade
por: Babl, Nathalie, et al.
Publicado: (2023)

Microbiome influencers of checkpoint blockade–associated toxicity
por: Wang, Yinghong, et al.
Publicado: (2023)

MTHFR act as a potential cancer biomarker in immune checkpoints blockades, heterogeneity, tumor microenvironment and immune infiltration
por: Peng, Jianheng, et al.
Publicado: (2023)

Update on checkpoint blockade therapy for lymphoma
por: Kline, Justin, et al.
Publicado: (2015)

Immune checkpoint blockade in ovarian cancer
por: Weiss, Lukas, et al.
Publicado: (2016)

LIGHTing tumor up for checkpoint blockade
por: Liang, Yong, et al.
Publicado: (2016)

Hallmarks of response to immune checkpoint blockade
por: Cogdill, Alexandria P, et al.
Publicado: (2017)

Immune-Checkpoint Blockade Therapy in Lymphoma
por: Kuzume, Ayumi, et al.
Publicado: (2020)

Activation of phagocytosis by immune checkpoint blockade
por: Li, Chia-Wei, et al.
Publicado: (2018)

Neutrophils in the era of immune checkpoint blockade
por: Faget, Julien, et al.
Publicado: (2021)

Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma
por: Cooper, Zachary A., et al.
Publicado: (2016)

Interpreting Deactivations in Neuroimaging
por: Hayes, Dave J., et al.
Publicado: (2012)

Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure
por: Miller, Sally, et al.
Publicado: (2018)

High‐grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF‐1
por: Steins, Anne, et al.
Publicado: (2020)

An immunomodulatory signature of responsiveness to immune checkpoint blockade therapy
por: Shen, Hongru, et al.
Publicado: (2020)

Analyzing Gene Expression from Whole Tissue vs. Different Cell Types Reveals the Central Role of Neurons in Predicting Severity of Alzheimer’s Disease
por: Stempler, Shiri, et al.
Publicado: (2012)

Correction: Analyzing Gene Expression from Whole Tissue vs. Different Cell Types Reveals the Central Role of Neurons in Predicting Severity of Alzheimer’s Disease
por: Stempler, Shiri, et al.
Publicado: (2012)

Identifying Selectivity Filters in Protein Biosensor for Ligand Screening
por: Sahil, Mohammad, et al.
Publicado: (2023)

NKG2A‐checkpoint inhibition and its blockade critically depends on peptides presented by its ligand HLA‐E
por: Battin, Claire, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fo6mqi9ng5k9i2vboegsn6eaog